Clinical Trials on HPV Vaccine

Total 10185 results

National Institute of Allergy and Infectious Diseases...

Completed

VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults

Healthy Adult Immune Responses to Vaccine

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

HIV Infections | Cytomegalovirus Infections | Vaccine

United States
East Carolina University

Recruiting

Advancing Vaccine Equity Through Understanding Vaccine Hesitancy, Barriers, and Trust

Vaccine Hesitancy | Structural Barriers | Vaccine Trust

United States
Bandim Health Project
Odense University Hospital; Odense Patient Data Explorative Network; Municipality...

Completed

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

Covid19 | Immunosenescence | Vaccine Preventable Disease | Morbidity | Non-specific Effects of Vaccines | Heterologous Immunity

Denmark
National Institute of Allergy and Infectious Diseases...
Auro Vaccines LLC

Completed

Therapeutic Vaccine for HIV

HIV | Therapeutic Vaccine

United States
Muhimbili University of Health and Allied Sciences
Karolinska Institutet; Imperial College London; Medical Research Council; Ludwig-Maximilians... and other collaborators

Completed

A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique (TaMoVac II)

HIV | Safety | Immunogenicity | Vaccines

Tanzania, Mozambique
The Behavioural Insights Team
UNICEF; National Center for Disease Control and Public Health, Georgia; Information...

Not yet recruiting

SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3m4 in Persons With HIV-1 Suppressed on ART (CM HIV-Core008)

HIV-1-infection | HIV Vaccine

United States
National Institute of Allergy and Infectious Diseases...

Completed

HIV-1 Vaccine Test in Uninfected Adult Volunteers

HIV Seronegativity | AIDS Vaccines

United States
Centre National de la Recherche Scientifique, France
Université Paris-Dauphine; Fondation La main à la pâte; Direction de l Évaluation...

Completed

Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents (Kidivax)

Health Knowledge, Attitudes, Practice | Vaccine Hesitancy | Vaccine Refusal

France
Assistance Publique - Hôpitaux de Paris
Gilead Sciences

Terminated

HCV, HBV, HIV Testing During Consultation With Anesthesiologist (SAHARA)

Hiv | HBV | HCV

France
Children's National Research Institute
Pfizer

Completed

Comparison of Immunization Quality Improvement Dissemination Study (CIzQIDS)

Immunization | Hepatitis B Vaccine | Poliovirus Vaccine, Inactivated | DTaP Vaccine | MMR Vaccine | HIB-vaccine | Chickenpox Vaccine | Pneumococcal Polysaccharide Vaccine
Emergent BioSolutions
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults

Healthy Volunteer | HIV Vaccine

United States
Association Clinique Thérapeutique Infantile du...
Pfizer

Recruiting

National Bacterial Meningitis Study

Meningitis | Children, Only | Neonatal Infection | Meningococcal Vaccines | Pneumococcal Conjugate Vaccine | Antibiotic Treatment | H. Influenzae Vaccine | Case Fatality Rate

France
The University of Hong Kong

Completed

Volatility and Heterogeneity of Vaccine Sentiments Means Continuous Monitoring is Needed When Measuring Message Effectiveness

Vaccine-Preventable Diseases | Vaccine Refusal

Hong Kong
London School of Hygiene and Tropical Medicine
Mwanza Intervention Trials Unit, National Institute for Medical Research; York... and other collaborators

Active, not recruiting

Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania (Add-Vacc)

HPV Infection | Vaccine Preventable Disease

Tanzania
Meharry Medical College

Recruiting

A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families

Parents | HPV-Related Carcinoma | Human Papilloma Virus | Vaccine Refusal | Program, Communication

United States
Bandim Health Project
Statens Serum Institut; Research Center for Vitamins and Vaccines

Unknown

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children (RE-CAMP)

Mortality | Children | Oral Polio Vaccine | Morbidity | Measles Vaccination | Non-specific/Heterologous Effects of Vaccines

Guinea-Bissau
Tufts University
Merck Sharp & Dohme LLC

Not yet recruiting

The Impact of Community and Patient Engagement Practices on Vaccine Confidence in the United States

Vaccine Hesitancy
McMaster University
Merck Canada Inc.

Recruiting

Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon

Vaccine Refusal

Cameroon
Johns Hopkins Bloomberg School of Public Health

Completed

Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India

Vaccine Hesitancy

India
Yuzuncu Yıl University

Enrolling by invitation

VACCINE HESITATION

VACCINE HESITATION

Turkey
Dartmouth-Hitchcock Medical Center

Terminated

Trusted Messenger Intervention

Vaccine Hesitancy

United States
PATH
Bill and Melinda Gates Foundation; Children's Hospital Medical Center, Cincinnati and other collaborators

Completed

Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

Rotavirus Vaccine

South Africa
Duke University
University of South Carolina

Completed

Increase Vaccine Uptake in Adolescent in Rural South (INVEST)

Vaccine Hesitancy

United States
University of Florida

Completed

MenB Vaccine: Implementation Via Information, Empowerment and Accessibility (MenBVaccine)

Meningococcal Vaccine

United States
University of Manitoba
Canadian Immunization Research Network

Completed

Public Health Messages to Address Vaccine Hesitancy

Vaccine Hesitancy

Canada
International Centre for Diarrhoeal Disease Research...
Incepta Vaccine Limited

Completed

Non Inferiority Trial of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladesh.

Meningococcal Vaccine

Bangladesh
Jaye Shyken, MD

Completed

Vaccination Compliance

Vaccine Compliance

United States
Pfizer

Completed

A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years

Meningococcal Vaccine

United States, Canada, Finland, Italy, Poland, United Kingdom, Czech Republic, Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

Pneumococcal Vaccine

Korea, Republic of
Chulalongkorn University
HIV-NAT, Thai Red Cross - AIDS Research Centre; Chula Clinical Research Center...

Recruiting

Immunogenicity and Safety of Comvigen (Bivalent) Vaccine

Safety of a Single Dose of COMVIGEN Vaccine | Reactogenicity of a Single Dose of COMVIGEN Vaccine | Immunogenicity of a Single Dose of COMVIGEN Vaccine | Safety of a Single Dose of BIVALENT Pfizer/BNT Vaccine | Reactogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine | Immunogenicity...

Thailand
Assiut University

Not yet recruiting

Animal Bite Victims Seeking Medical Services at Concerned Hospitals

Vaccine-Preventable Diseases
Chulalongkorn University
BioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine... and other collaborators

Recruiting

Safety and Immunogenicity of ChulaCov19 BNA159 mRNA Vaccine

Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response... and other conditions

Thailand
University Medical Center Groningen
Radboud University Medical Center; Maastricht University Medical Center; UMC... and other collaborators

Completed

PREPARE-iVAC Trial (PREPARE-iVAC)

Vaccine Response | Immunosuppression | COVID-19 Vaccines | Varicella Zoster Vaccine

Netherlands
University of California, San Francisco
Stanford University; Wuqu' Kawoq, Maya Health Alliance

Not yet recruiting

Culturally and Linguistically Appropriate Vaccine Education (CLAVE)

Vaccine Hesitancy

Guatemala
Emory University
Defense Advanced Research Projects Agency

Recruiting

Systems Biological Assessment of the Durability of Vaccine Responses (DARPASB)

Vaccine Response

United States
Nepal Health Research Council
Microbe Literacy Initiative; Partnership for Sustainable Development Nepal...

Not yet recruiting

Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal

Vaccine Acceptance

Nepal
PharmaJet, Inc.
National Cancer Institute (NCI); National Institutes of Health (NIH)

Withdrawn

Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

Vaccine Reaction

Indonesia
IRCCS San Camillo, Venezia, Italy

Completed

Antibody Response and Longevity Post SARS-CoV-2 Vaccine (SARS-AB) (SARS-AB)

Vaccine Reaction

Italy
University of Michigan
National Institute of Allergy and Infectious Diseases (NIAID); Shanghai Municipal...

Terminated

Optimizing HPV Vaccine Introduction in Shanghai, China

Vaccine Refusal

China
Lahore General Hospital

Active, not recruiting

Booster Effect of mRNA Vaccine on Antibody Response for SARS-CoV-2 After Complete Vaccination With Sinos

Vaccine Reaction

Pakistan
Chinese University of Hong Kong

Completed

An Online Intervention Promoting HPV Vaccination Among Chinese MSM

Vaccine Refusal

Hong Kong
Cedarville University
Merck Investigator Studies Program; Rocking Horse Community Health Center

Completed

Motivational Interviewing and Vaccine Hesitancy in Children (MOTIVE)

Vaccine Hesitancy

United States
Medical University of Vienna

Completed

Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®

Vaccine Efficacy
Vanderbilt University

Completed

Educational Intervention to Improve Vaccine Acceptance

Vaccine Hesitancy

United States
Pfizer

Completed

Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age

Meningococcal Vaccine

Finland, Spain, Poland
Pfizer

Completed

A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

Meningococcal Vaccine

United States
Murdoch Childrens Research Institute
Pasteur Institute, Ho Chi Minh City

Completed

Trial of Simplified Pneumococcal Vaccination in Vietnam II (VPTII)

Pneumococcal Vaccine

Vietnam
Pfizer

Completed

A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.

Meningococcal Vaccine

United States, Finland, Czechia, Poland

Clinical Trials on HPV Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations